Abstract ▼ Vitamin D's canonical role are its effects exerted on the musculoskeletal system. In the last decades the importance of this hormone has been studied in the context of extraskeletal health. Hypovitaminosis D and several polymorphic variants of genes coding proteins crucial in the transport, metabolism and effects of vitamin D have been associated with negative health outcomes.
In this review the current state of knowledge on the role of vitamin D in thyroid disorders is pre-sented. The review is based on a literature search of the PubMed database performed in December 2014. The following search terms were used in conjunction with 'vitamin D': thyroid cancer, Graves', Hashimoto, thyroiditis, autoimmune thyroid, AITD, nodules, hyperthyroidism, and hypothyroidism. Currently, similarly to other extraskeletal health outcomes, a clear role of vitamin D has not been demonstrated in thyroid disorders. Further research is necessary to fully elucidate the importance of vitamin D in case of thyroid disease.
commonly referred to with this name. The former is synthesized in the skin upon exposure to ultraviolet B (UVB) radiation by 7-dehydrocholesterol reductase and acquired from few dietary sources (mainly fatty fish), while the latter is synthesized by plants and fungi, which may constitute vitamin D2 dietary source for humans. Both vitamin D2 and D3 are hydroxylated in the liver to 25-hydroxyvitamin D (25(OH)D, calcidiol), which is the major circulating and storage form of vitamin D. It has little biological activity, however, its serum concentration is universally acknowledged to reflect vitamin D status (Muscogiuri et al. 2014; Prietl et al. 2013 ). The active hormone is acquired by hydroxylation of 25(OH)D to 1,25-dihydroxyvitamin D (1,25(OH) 2 D, calcitriol). This conversion takes place mainly in the kidney and is regulated by a negative feedback by elevated calcitriol concentrations and fibroblast growth factor 23 (FGF23). However, calcitriol is also synthesized in other cell types (immune cells in particular) as an auto-and paracrine cytokine, without the above regulatory feedback (Prietl et al. 2013 ). It has been proposed that serum calcidiol level serves as the main determining factor of extrarenal calcitriol synthesis (Jones 2013 Regarding thyroid disorders, the antiproliferative and prodifferentiating effects of calcitriol come to play in thyroid tumorigenesis, its role in the modulation of the immune system has been pointed out in autoimmune thyroid disease (AITD). Also, in this review the role of vitamin D in the context of thyroid function, hypo-and hyperthyroidism will be presented in brief.
Aim ▼
In this review a summary of the current state of knowledge on the role of vitamin D in thyroid disorders will be presented.
Methods

▼
The review is based on an electronic search of literature in the PubMed database performed in December 2014 using the following search terms: vitamin D thyroid cancer; vitamin D thyroiditis; vitamin D Hashimoto; vitamin D Graves; vitamin D goiter; vitamin D hyperthyroidism; vitamin D hypothyroidism; and vitamin D nodule. Papers were included in the review based on screening of the titles and/or abstracts.
Vitamin D and Thyroid Function ▼
The thyroid gland serves as a synthesis, storage and release organ for the thyroid hormones (THs), thyroxine (T4) and triiodothyronine (T3), which are vital for maintaining appropriate function of all tissue and cell types. Their synthesis is stimulated by the thyroid stimulating hormone (TSH) released by the pituitary. Both THs constitute a phenyl ring and a tyrosine molecule; 2 iodine atoms are bound to the tyrosine ring and 2 (in case of T4) or one (T3) iodine atom is linked to the phenyl ring (Ross 2015) . Only the thyroid gland produces thyroxine, which constitutes approximately 85 % of both hormones' secretion, while T3 is mainly obtained by deiodination of T4 in peripheral tissues and has a 3-to 8-fold greater biological activity compared to T4; the latter is considered a prohormone (Szczeklik and Augustynowicz-Kopeć 2011). At the microscopic level the thyroid is composed of follicles: follicular cells surround colloid with mostly thyroglobulin (Tg), a glycoprotein that serves as a scaffold for TH production. In brief, iodide -necessary for TH synthesis -is actively taken up into follicular cells by a transmembrane sodium iodine symporter (NIS) located at the cells' basolateral membrane (Ross 2015) . Iodide diffuses to the apical (lumen-neighboring) cellular surface, from where it is transferred into the colloid (at least in part by pendrin, an iodidechloride transporter located in the membrane) (Bizhanova and Kopp 2011). Thyroid peroxidase (TPO) catalyzes oxidation and organification of iodide into tyrosine residues of thyroglobulin, which yields mono-and diiodotyrosine (MIT and DIT, respectively), as well as coupling of 2 DITs into T4 and one MIT with one DIT into T3. TH are secreted into extracellular fluid from follicular cells after endocytosis of colloid droplets, which fuse with lysosomes to enable hydrolysis of Tg to T4, T3 (and aminoacids constituting the protein) (Ross 2015) . Parafollicular C cells are located among or in the wall of thyroid follicles and they secrete calcitonin in the presence of hypercalcemia. The role of this hormone is probably redundant in humans, since calcium-phosphate homeostasis is affected by neither excessive (i. e., in medullary thyroid cancer patients), nor decreased levels of calcitonin (e. g., in post-thyroidectomy patients) (Clinckspoor et al. 2013 ). Clinckspoor and co-authors discussed experimental and clinical data on the role of vitamin D in thyroid function in their review paper. In experiments with rodents: high doses of calcitriol did not alter TSH, nor fT4 levels in rats; severely vitamin D-deficient This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
diet led to a decrease in TSH but not fT4; in VDR knock-out mice TSH levels were minimally lower -without alteration in thyroid morphology or function. Further, as mentioned by these researchers (and also to our knowledge) no studies examining the effect of vitamin D on thyroid function have been performed, although basal serum TSH levels in subjects with calcidiol lower than or equal to 10 ng/ml were not significantly different vs. subjects with 25(OH) of at least 40 ng/ml in a cohort study involving inpatients without thyroid disease history (Clinckspoor et al. 2013 ). Contrasting results were found for: younger men (lowest age tertile of participants aged 15-98) in a randomly selected Thai cohort of 2 582 by Chailurkit, Aekplakorn and Ongphiphadhanakul, as well as for middle-aged and elderly Chinese men in a cohort On the other hand, Bouillon, Muls and De Moor reported unaltered calcidiol levels in both hypo-and hyperthyroid patients compared to controls (n = 23, 20 and 81 respectively). In this study calcitriol was also measured: its increased levels were found in hypothyroid (73 pg/ml) patients and decreased in hyperthyroid (28 pg/ml), compared to controls (43 pg/ml). DBP concentration did not differ between controls and hyperthyroid subjects, and in hypothyroid it was just 17 % higher, which does not account for calcitriol concentration differences (Bouillon et al. 1980) . In regard to parafollicular cells, while in vitro experiments and in vivo studies in rodents demonstrate a negative feedback loop between calcitriol and calcitonin synthesis, important differences exist between humans and rodents in respect to C-cells: in physiological conditions in the former calcitonin is thought to be of no significance. Lack of association between 25(OH)D and calcitonin was shown in the same Belgian hospital patient cohort as mentioned above. After excluding several groups of patients (proton pump inhibitor users, those with renal failure, known thyroid or parathyroid disease) no significant differences were recorded in calcitonin levels between subjects with low and high vitamin D status (defined as above) (Clinckspoor et al. 2013 
Calcitriol and vitamin D signaling in thyroid cancer
As mentioned above, calcitriol is the active form of vitamin D, which, among all vitamin D forms, exerts the most of biologic effects by binding to VDR. Consequently, the enzymes: 1-aphahydroxylase (CYP27B1), which catalyzes the conversion of calcidiol to calcitriol, and 24-hydroxylase (CYP24A1), calcitriol inactivating enzyme, are crucial in governing the availability of active vitamin D (Clinckspoor et al. 2013 ). Also, understandably, the effects of calcitriol depend on VDR, whose polymorphic variants have been studied to a limited extent in case of thyroid cancer. In 3 studies decreased serum 1,25(OH) 2 D concentrations in thyroid cancer patients compared to controls were reported. In neither of these did 25 These findings provide perspectives for the possibility of future treatment using VDR signaling in thyroid cancer ( • ▶ Fig. 1 ). lymphocytes, antigen-presenting cells (e. g., dendritic cells), and macrophages. Calcitriol regulates inflammatory cytokine production and inhibits the proliferation of proinflammatory cells (Yin and Agrawal 2014). The innate immune system is activated by vitamin D, which has been demonstrated by hormone's effect on monocytes and macrophages in particular. An opposite, inhibitory, effect has been shown for the acquired immune response (Bouillon 2014) , which results in an enhanced tolerance of this system (Bizzaro and Shoenfeld 2015) . The latter immunomodulatory effect of vitamin D has led to investigating its role in a number of autoimmune diseases, which have been associated with hypovitaminosis D (Bizzaro and Shoenfeld 2015; Effraimidis and Wiersinga 2014). Several observations have been made in regard to autoimmune thyroiditis.
Vitamin D and Autoimmune Thyroid Disease
In an animal in vivo autoimmune thyroiditis model, CBA strain (general purpose) mice were sensitized with porcine thyroglobulin and treated intraperitoneally with calcitriol at subtherapeutic doses, i. e., 0.1-0.2 micrograms per kg body weight daily. This treatment led to a reduction in the severity of inflammatory lesions in the gland (Fournier et al. 1990 ). The incidence of thyroiditis was lower in animals which were treated with both calcitriol and cyclosporine A (subtherapeutic doses) (Fournier et al. 1990; Chen et al. 2002) . In another study, female Wistar rats, also sensitized with porcine thyroglobulin, were given calcitriol by intraperitoneal injection (5 micrograms per kg every 48 h) prior to or following immunization. In the treated animals the thyroid appeared intact, which contrasted with typical inflammatory changes of the thyroid in the placebo group based study in Delhi where 642 students, teachers and staff were enrolled, only a very weak correlation between serum 25(OH)D and anti-TPO antibody titers was found (r = − 0.08) after results were adjusted for age (Goswami et al. 2009 ). In another report, 67 subjects from the Amsterdam AITD cohort, i. e., firstand second-degree relatives of overt AITD patients, developed anti-thyroid antibodies during a 5-year follow-up. However, their vitamin D status did not differ from that of healthy controls. Moreover, in this study, seronegative cohort cases had higher 25(OH)D levels than age-matched controls without AITD family history (Effraimidis et al. 2012 ). Furthermore, no significant difference in vitamin D levels was found between 2 DM type 1 patients aged 10-19, i. e., study participants with and without thyroid-specific autoantibodies (n = 19 for both) (Demir et al. Table 2 ).
2014) ( • ▶
The risk of AITD according to VDR gene polymorphisms was summarized in a recent meta-analysis including 8 studies (5 European, 2 Asian, and 1 African). Authors conclude that a decrease in AITD risk is associated with BsmI or TaqI polymorphisms, and, that ApaI or FokI polymorphisms are not significantly associated with AITD risk (Feng et 
Vitamin D and Hashimoto's thyroiditis
Regarding vitamin D status and Hashimoto's thyroiditis, Bozkurt and co-workers reported correlations between 25(OH)D concentrations and: thyroid volume (r = 0.15), as well as anti-TPO (r = − 0.36) and anti-TG (r = − 0.34) levels. In their study 180 HT euthyroid patients, 180 newly-diagnosed HT subjects and 180 healthy controls were enrolled. Calcidiol levels lower than 10 ng/ ml were recorded in 48.3, 35 and 20.5 % of subjects respectively (Bozkurt et al. 2013 ). In another report, vitamin D deficiency prevalence was significantly higher in children with HT (n = 78) than in healthy controls (n = 74), i. e., 73 (Stefanic et al. 2005) ; TaqI TT and FokI FF genotypes were significantly more common in HT patients (n = 111) than healthy controls (n = 159) in Turkey (Yazici et al. 2013) . Results concerning associations between HT and polymorphic variants of other genes vital in vitamin D metabolism were mentioned above. 
Vitamin D and Graves' disease
Vitamin D and postpartum thyroiditis
Krysiak, Kowalska and Okopień studied 4 groups of non-lactating women: hypothyroid (n = 14) and euthyroid (n = 14) subjects with postpartum thyroiditis, participants with non-autoim- This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
mune hypothyroidism (n = 16), and an euthyroid group without thyroid autoimmunity (n = 15). Serum 25(OH)D concentrations among thyroiditis patients were lower than in the remaining subjects, as well as lower in hypo-than euthyroid women (respective means of the 4 groups: 18, 30, 38 and 53 ng/ml). Further, anti-TPO and anti-TG antibody titers correlated with calcidiol levels (r coefficients in the range of − 0.22 to − 0.34). Hypothyroid subjects were treated with L-thyroxine, however, researchers observed an increase in calcidiol levels only in postpartum thyroiditis patients (thyroid function improved in both groups that required treatment). A correlation between 25(OH)D levels after thyroxine treatment and antibody titers was recorded too (r = − 0.3 and − 0.2 for respectively anti-TPO and anti-TG). Authors mention the major limitations of their results, among them the low number of subjects, no significant difference in calcidiol levels between groups after taking into account the season of sample collection (Krysiak et al. 2014 ). As can be drawn from this review, research on vitamin D and thyroid disorders too has underlined hormone's significance -particularly in case of gland's cancers and autoimmune diseases. Still, in many points accumulated data are inconclusive, many unresolved questions remain, therefore, it remains necessary to perform further studies that would affect clinical approaches to thyroid disease. Studies demonstrating associations of hypovitaminosis D with AITD and basic research rationale underlying this relation might lead to recommendations of vitamin D supplementation for the patients, however, currently such treatment is still controversial (Bizzaro and Shoenfeld 2015) . Also, at this point, clinical choices are not dependent on possible associations between thyroid disease and genetic variants of VDR and other proteins important in vitamin D metabolism and transport. Applying antineoplastic effects of calcitriol in a clinical setting remains a possible future perspective. Currently, in the context of thyroid disease, but also in a broader perspective, no highly convincing data for any health outcome are available. Moreover, vitamin D supplementation has not affected disease occurrence in intervention studies, as summarized in 2 recent reviews. The associations between vitamin D deficiency and disease may indicate that 25(OH)D is only a marker of ill health (Theodoratou et al. 2014; Autier et al. 2014 ).
Conclusions
